Durham-based Atsena Therapeutics has raised $150 million to advance gene therapies for preventing or reversing types of ...

VQ Biomedical, spun out of Duke University, has developed a novel, minimally invasive catheter designed to deliver oxygen directly to the bloodstream. The catheter bypasses the lungs, giving ARDS ...

Hear from dynamic founders who are building successful businesses in innovative industries. As part of UNC's Insight and Action Series, this event will showcase the journeys and lessons learned by ...

In his talk, Dr. Perou will share his journey from research to entrepreneurship, highlighting the challenges and lessons learned in transforming his cancer genomics research into a successful startup ...

Durham-based Precision BioSciences Inc. has received investigational new drug (IND) clearance from the U.S. Food and Drug Administration (FDA) for PBGENE-HBV, an in vivo gene editing program designed ...

As part of the Distinguished Speaker Series, Charlotte Biology and Biotechnology (CBB) Exchange Group presents "Succinate Signaling Mediated Host-Microbial Interactions in Inflammatory Diseases," ...

GreenLight Biosciences, Inc., a Boston-based agtech company with lab, office and greenhouse space in RTP, has closed a Series C funding round, including a $25 million investment from a new investor, ...

Greater Charlotte is home to a robust, expanding life sciences cluster with a plethora of international firms. Assets in the region span medtech/medical device development and manufacturing, ...